✨ Medicines Consent Notices




1 APRIL 2004

NEW ZEALAND GAZETTE, No. 39

979

Dated this 23rd day of March 2004.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go2029

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Panadol Mini Caps (pharmacy only)

Active Ingredient: Paracetamol 500mg

Dosage Form: Coated tablet

New Zealand Sponsor: GlaxoSmithKline (NZ) Limited

Manufacturer: GlaxoSmithKline Australia Pty Limited, Ermington, New South Wales, Australia

Product: Panadol Mini Caps (general sale)

Active Ingredient: Paracetamol 500mg

Dosage Form: Coated tablet

New Zealand Sponsor: GlaxoSmithKline (NZ) Limited

Manufacturer: GlaxoSmithKline Australia Pty Limited, Ermington, New South Wales, Australia

Product: Resolve Jock Itch

Active Ingredient: Miconazole nitrate 2%w/w

Dosage Form: Topical cream

New Zealand Sponsor: Douglas Pharmaceuticals Limited

Manufacturer: Ego Pharmaceuticals Pty Limited, Braeside, Victoria, Australia

Dated this 29th day of March 2004.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go2179

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Viramune

Active Ingredient: Nevirapine hemihydrate 10.35mg/mL equivalent 10mg/mL nevirapine

Dosage Form: Oral suspension

New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited

Manufacturer: Roxane Laboratories Inc, Columbus, Ohio, United States of America

Note: This consent is valid for two years from 2 March 2004.

Dated this 29th day of March 2004.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go2180

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Aldara

Active Ingredient: Imiquimod 5%w/w

Dosage Form: Topical cream

New Zealand Sponsor: 3M New Zealand Limited

Manufacturer: 3M Health Care (UK) Limited, Loughborough, Leicestershire, England

Product: Avandia

Active Ingredient: Rosiglitazone maleate 5.3mg equivalent to 4mg rosiglitazone

Dosage Form: Film coated tablet

New Zealand Sponsor: GlaxoSmithKline (NZ) Limited

Manufacturer: SB Pharmaco PR Inc, Barrio Certenejas, Cidra, Puerto Rico



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2004, No 39


Gazette.govt.nz PDF NZ Gazette 2004, No 39





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
23 March 2004
Medicines, Consent, Distribution, Panadol Mini Caps, Resolve Jock Itch
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Renewal of Provisional Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
29 March 2004
Medicines, Provisional Consent, Renewal, Viramune
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
29 March 2004
Medicines, Consent, Changed, Aldara, Avandia
  • DON MATHESON, Deputy Director-General, Public Health